Relationship between asprosin and insulin resistance in hypothyroidism
Open Access
- 4 May 2026
- journal article
- research article
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 51 (4) , 690-696
Abstract
Objectives: Thyroid dysfunction is a common disorder associated with changes in body metabolism and low-grade inflammation. Associated with insulin resistance (IR), asprosin is a newly discovered peptide hormone. Asprosin promotes hepatic glucose production. This study was designed to evaluate the relationship between asprosin and IR in patients with overt and subclinical hypothyroidism and to compare the findings with a euthyroid healthy control group. Methods: The study included 30 patients diagnosed with hypothyroidism, 29 patients diagnosed with subclinical hypothyroidism, and 30 healthy individuals. Serum asprosin concentrations, glucose concentrations, and HOMA-IR indices of the groups were compared. Results: The mean age was 37.8 years, and 77.5 % (69/89) of participants were female. We found that circulating asprosin concentrations were elevated in patients with overt and subclinical hypothyroidism compared to controls. Asprosin concentrations were positively correlated with TSH, Anti TPO, Anti TG, glucose, insulin, HOMA-IR and negatively correlated with FT4 and FT3. Conclusions: For the first time in the literature, this study has shown that asprosin concentration is increased in patients with hypothyroidism, and that increased asprosin concentrations are associated with increased serum glucose concentration and HOMA-IR index. Therefore, asprosin may be a useful new marker for early metabolic disorders in hypothyroid patients.Keywords
This publication has 26 references indexed in Scilit:
- Asprosin: the potential player in combined double diabetes and hypothyroidismIrish Journal of Medical Science (1971 -), 2024
- Adipocytokines: Are they the Theory of Everything?Cytokine, 2020
- OLFR734 Mediates Glucose Metabolism as a Receptor of AsprosinCell Metabolism, 2019
- Asprosin attenuates insulin signaling pathway through PKCδ‐activated ER stress and inflammation in skeletal muscleJournal of Cellular Physiology, 2019
- Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammationMolecular and Cellular Endocrinology, 2019
- Direct correlation between serum homocysteine level and insulin resistance index in patients with subclinical hypothyroidism: Does subclinical hypothyroidism increase the risk of diabetes and cardio vascular disease together?Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2018
- Direct effects of thyroid hormones on hepatic lipid metabolismNature Reviews Endocrinology, 2018
- Asprosin is a centrally acting orexigenic hormoneNature Medicine, 2017
- Asprosin, a Fasting-Induced Glucogenic Protein HormoneCell, 2016
- Subclinical thyroid diseaseThe Lancet, 2012